首页/数据集/A COMPARISON OF THE ANTI-RHINOVIRAL DRUG BINDING POCKET IN HRV14 AND HRV1A

A COMPARISON OF THE ANTI-RHINOVIRAL DRUG BINDING POCKET IN HRV14 AND HRV1A

NIAID Data Ecosystem2026-05-02 收录

抗病毒药物设计

病毒蛋白结构

数据链接：

https://www.rcsb.org/structure/2HWE 数据链接链接失效反馈

官方服务：

资源简介：

A COMPARISON OF THE ANTI-RHINOVIRAL DRUG BINDING POCKET IN HRV14 AND HRV1A

应用场景：

创建时间：

2024-05-29

抗病毒药物设计

结构生物学

Structure of FIPV main protease in complex with dual inhibitors Descriptor: 1,2-ETHANEDIOL, N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL-L-VALYL-N~1~-((1R,2Z)-4-(BENZYLOXY)-4-OXO-1-{[(3R)-2-OXOPYRROLIDIN

Protein Data Bank Japan2024-11-13 更新100

Structure-Based Stabilization of Non-native Protein–Protein Interactions of Coronavirus Nucleocapsid Proteins in Antiviral Drug Design

抗病毒药物设计

蛋白质相互作用

Structure-based stabilization of protein–protein interactions (PPIs) is a promising strategy for drug discovery. However, this approach has mainly focused on the stabilization of native PPIs, and non-

NIAID Data Ecosystem60

Crystal structure of SARS-CoV-2 NSP3 Macrodomain in complex with ASAP-0000601-001

病毒蛋白结构解析

抗病毒药物设计

Crystal structure of SARS-CoV-2 NSP3 Macrodomain in complex with ASAP-0000601-001

NIAID Data Ecosystem30

BDBV-289 bound to EBOV GPdMuc Makona

埃博拉病毒抗体

病毒蛋白结构

BDBV-289 bound to EBOV GPdMuc Makona

NIAID Data Ecosystem70

Crystal Structure of uncleaved SARS-CoV-2 Main Protease C145S mutant in complex with Nirmatrelvir

抗病毒药物设计

蛋白质晶体学

Crystal Structure of uncleaved SARS-CoV-2 Main Protease C145S mutant in complex with Nirmatrelvir Descriptor: (1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-

Protein Data Bank Japan2024-10-16 更新50

A COMPARISON OF THE ANTI-RHINOVIRAL DRUG BINDING POCKET IN HRV14 AND HRV1A

资源简介：

相关数据集